NMDA ε 4 Antibodies

Santa Cruz Biotechnology offers a broad range of NMDA ε 4 Antibodies for neuroscience and cellular signaling research. NMDA ε 4 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NMDA ε 4 plays a crucial role in synaptic plasticity and memory function, acting as a key component of the NMDA receptor complex. Its involvement in excitatory neurotransmission makes it essential for understanding various neurological disorders and cognitive processes. Research on NMDA ε 4 can provide insights into the mechanisms underlying synaptic transmission and potential therapeutic targets for neurodegenerative diseases. NMDA ε 4 is particularly important in studying learning and memory formation processes at the molecular level. Understanding NMDA ε 4 function has significant implications for developing treatments for conditions such as Alzheimer's disease and other memory-related disorders. Investigating NMDA ε 4's role in neural plasticity can reveal new pathways for therapeutic intervention in neurological conditions. Santa Cruz Biotechnology monoclonal antibodies for NMDA ε 4 enable researchers worldwide to advance our understanding of neural function and contribute to developing new therapeutic strategies for neurological disorders.